Healthcare -
Biotechnology - NASDAQ - US
$ 0.52
-2.62 %
$ 20.1 M
Market Cap
-0.18
P/E
ATHA - STOCK-BASED COMPENSATION
Stock-based Compensation ATHA - Athira Pharma, Inc.
10.6 M
LAST VALUE
51.59%
2 YEAR CAGR
122.23%
5 YEAR CAGR
0.00%
10 YEAR CAGR